Compare
Labcorp vs Progyny (LH vs PGNY)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Labcorp (LH) returned +46.2% and Progyny (PGNY) +84.5%; so far this year the figures are +46.1% and +35.7%.
Labcorp is the larger company by market value, about 11.6 times the size of Progyny.
On trailing earnings, LH trades at 30.1 times and PGNY at 32.0 times.
Revenue grew +6.0% at LH and +5.5% at PGNY over the last year.
LH yields 0.79%. PGNY pays no dividend.
Data as of the latest close. Not investment advice.
Relative performance
| LH | PGNY | |
|---|---|---|
| Price | $366.57 | $34.84 |
| 1-day | +0.90% | +1.37% |
| YTD | +46.11% | +35.67% |
| 1 year | +46.22% | +84.53% |
| 3 years | +79.74% | +14.49% |
| Market cap | $29.8B | $2.6B |
| P/E | 30.1 | 32.0 |
| P/S | 2.04 | 1.92 |
| P/B | 3.36 | 6.20 |
| Revenue growth | +6.00% | +5.50% |
| EPS growth | +19.60% | +73.00% |
| Gross margin % | 29.0 | 24.9 |
| Net margin % | 6.9 | 6.8 |
| ROE % | 11.3 | 22.0 |
| Debt / equity | 0.66 | 0.00 |
| FCF yield % | 4.3 | 7.0 |
| Dividend yield % | 0.79 | — |
| Beta | 0.38 | -0.08 |
| RSI (14) | 69.9 | 80.3 |
| Technical rating |